-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-10-18
Values as of: 2019-10-18
The investment seeks daily investment results, before fees and expenses, that correspond to the inverse (-1x) of the daily performance of the Dow Jones U.S. FinancialsSM Index. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as the inverse (-1x) of the daily return of the index. The index measures the performance of the financial services sector of the U.S. equity market. The fund is non-diversified.
Company Website : www.proshares.com
Currency: USD
Country : USA
Inception Date: 10/06/2008
Primary Benchmark: DJ US Financial TR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 1.25%
Management Expense Ratio: 0.95 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| CVE | Cenovus Energy Inc | 5.88 % |
| EMMA | Emmaus Life Sciences Inc | 4.83 % |
| ABL | Abacus Life Inc. | 4.46 % |
| CUBI | Customers Bancorp Inc | 2.98 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| SOJE | SOJE | 0.00 % |
-0.42 (-2.11%) |
USD 65.72B |
| JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
-0.31 (-0.55%) |
USD 32.43B |
| DTB | DTB | 0.00 % |
-0.23 (-1.13%) |
USD 26.58B |
| DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
-0.14 (-0.46%) |
USD 26.00B |
| GBTC | Grayscale Bitcoin Trust (BTC) | 0.00 % |
+0.70 (+1.23%) |
USD 23.75B |
| JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
+0.02 (+0.04%) |
USD 22.73B |
| SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.05 (+0.05%) |
USD 19.79B |
| AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
-0.35 (-0.39%) |
USD 10.49B |
| DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
-0.18 (-0.46%) |
USD 10.15B |
| DFAT | Dimensional U.S. Targeted Valu.. | 0.00 % |
-0.31 (-0.60%) |
USD 9.40B |
N/A
| Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -19.11% | 5% | F | 10% | F | ||
| Dividend Return | 0.75% | 19% | F | 12% | F | ||
| Total Return | -18.36% | 5% | F | 10% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -12.20% | 12% | F | 23% | F | ||
| Dividend Return | 1.11% | 26% | F | 18% | F | ||
| Total Return | -11.09% | 12% | F | 22% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -47.77% | 10% | F | 15% | F | ||
| Dividend Return | 0.74% | 7% | C- | 4% | F | ||
| Total Return | -47.02% | 8% | B- | 11% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -10.22% | 6% | D- | 11% | F | ||
| Dividend Return | -10.06% | 5% | F | 9% | A- | ||
| Total Return | 0.16% | 7% | C- | 4% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 9.34% | 56% | F | 74% | C | ||
| Risk Adjusted Return | -107.76% | 3% | F | 2% | F | ||
| Market Capitalization | 0.03B | 25% | F | 10% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
